ARK Genomic Revolution ETF vs JetBlue Airways Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while JetBlue Airways Corporation trades at $5.81 (market cap $2.19B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | JBLU | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.55 | $6.46 |
52-Week Low | $24.02 | $4.03 |
Market Cap | — | $2.19B |
Enterprise Value | — | $9.56B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →